Skip to Content

Mustang Bio Inc MBIO

Morningstar Rating
$1.04 +0.09 (9.47%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

MBIO is trading at a 47% discount.
Price
$1.04
Fair Value
$5.78
Uncertainty
Extreme
1-Star Price
$32.78
5-Star Price
$2.86
Economic Moat
Mywsnsr
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MBIO is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.95
Day Range
$0.901.07
52-Week Range
$0.908.17
Bid/Ask
$0.96 / $1.12
Market Cap
$10.81 Mil
Volume/Avg
210,074 / 154,977

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
80

Comparables

Valuation

Metric
MBIO
SWTX
KPTI
Price/Earnings (Normalized)
Price/Book Value
77.965.68
Price/Sales
561.241.15
Price/Cash Flow
Price/Earnings
MBIO
SWTX
KPTI

Financial Strength

Metric
MBIO
SWTX
KPTI
Quick Ratio
0.666.213.14
Current Ratio
0.746.413.37
Interest Coverage
−38.92−5.45
Quick Ratio
MBIO
SWTX
KPTI

Profitability

Metric
MBIO
SWTX
KPTI
Return on Assets (Normalized)
−106.47%−39.61%−42.20%
Return on Equity (Normalized)
−264.57%−45.43%
Return on Invested Capital (Normalized)
−149.65%−49.28%−111.18%
Return on Assets
MBIO
SWTX
KPTI
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRVdhv$595.3 Bil
VRTX
Vertex Pharmaceuticals IncJkbfw$106.3 Bil
REGN
Regeneron Pharmaceuticals IncJntsfll$105.4 Bil
MRNA
Moderna IncYddq$39.8 Bil
BNTX
BioNTech SE ADRPfxwp$22.1 Bil
ARGX
argenx SE ADRNbbt$21.5 Bil
ALNY
Alnylam Pharmaceuticals IncWthty$18.6 Bil
BMRN
Biomarin Pharmaceutical IncKdpkxr$15.8 Bil
RPRX
Royalty Pharma PLC Class ASwvlzt$13.4 Bil
INCY
Incyte CorpByqgt$12.9 Bil

Sponsor Center